People who have experienced the following side effects after taking Xarelto may be eligible to file for a lawsuit after dealing with a:
• Brain hemorrhage
• Hemorrhagic stroke
• Wrongful death as the result of bleeding problems
• Gastrointestinal bleeding or internal bleeding
The makers of Xarelto failed to adequately warn people about the dangerous side effects associated with using this medication. If you or one of your family members wants to file a lawsuit against the makers of Xarelto, then you should contact a Xarelto law firm.
Bleeding Problems Associated With Xarelto
Xarelto first made its debut in 2011. It was developed by Janssen Pharmaceuticals, which is a pharmaceutical company of Johnson and Johnson. This medication was created to treat deep vein thrombosis, pulmonary embolism and blood clots. It is often prescribed to people who suffer from non-valvular atrial fibrillation, or AF. Additionally, it is also prescribed to reduce the risk of blood clots in patients who have had hip or knee replacement surgery.
Every blood thinner increases the risk of internal bleeding. However, Xarelto carries a much higher risk of bleeding, and the makers of the drug failed to mention that. The creators of this drug also failed to mention that there is no specific antidote available for Xarelto. Doctors can very easily reverse the effects of warfarin, which is also a blood thinner. However, Xarelto often causes uncontrollable bleeding, which increases the risk of death and serious injury.
Allegations
There was also a lawsuit filed against Pradaxa, which are similar blood thinners. People stated that they were not properly warned about the bleeding risk. Boehringer Ingelheim, which is the creator of Pradaxa agreed to pay the victims over $650 million in compensation. Users of Xarelto may be able to get similar compensation.
The following allegations have been made in Xarelto injury lawsuits:
• Failure to adequately warn people about the risk of bleeding
• Withheld important information about the lack of antidote
• Aggressively marketed the drug and encouraged doctors to use a version of the drug that was more dangerous and expensive